Alexa
  • Directory of Taiwan

Merck cancer drug approved

Merck cancer drug approved

A Merck & Co. Inc. drug received U.S. government approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma.
The drug is to be used when the disease persists, gets worse or comes back during or after treatment with other medicines, the FDA said.
Zolinza is the first new cancer drug from U.S.-based Merck in roughly 20 years.
While the market as a treatment for the cancer, also called CTCL, is limited, Merck is studying the drug as a tumor-fighting treatment in many other cancers, including of the breast and lung. Additional approvals from the FDA could vastly expand the market for the drug, also known as vorinostat.
___
On the Net:
http://www.fda.gov/


Updated : 2021-05-07 12:07 GMT+08:00